SLU-PP-322 (5mg) and enhanced re-establishment of tissue

and enhanced re-establishment of tissue architecture compared to either peptide alone

and healthy human volunteer studies using the individual peptides or similar GHRH+GHS combinations

ARA-290 reduced pro-inflammatory cytokines (TNF-α

reduced fibrosis

and related pathways in various in vitro and animal model systems

SLU-PP-322 (5mg) and enhanced re-establishment of tissueSLU PP 322 Product Description Overview SLU PP 322 is a synthetic small molecule engineered to function as a potent, non selective agonist of the estrogen related receptors (ERRs), with a notable affinity for ERR. Designed for cutting edge research in metabolic health and exercise mimetics, SLU PP 322 activates ERR pathways without eliciting estrogenic effects, positioning it as an invaluable asset for studying cellular energy regulation,